- Home
- FCF vs TVTX Comparison
FCF vs TVTX Comparison
Compare FCF & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCF
- TVTX
- Stock Information
- Founded
- FCF 1934
- TVTX 2008
- Country
- FCF United States
- TVTX United States
- Employees
- FCF N/A
- TVTX N/A
- Industry
- FCF Major Banks
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- FCF Finance
- TVTX Health Care
- Exchange
- FCF Nasdaq
- TVTX Nasdaq
- Market Cap
- FCF 1.7B
- TVTX 1.9B
- IPO Year
- FCF N/A
- TVTX N/A
- Fundamental
- Price
- FCF $15.47
- TVTX $19.13
- Analyst Decision
- FCF Buy
- TVTX Strong Buy
- Analyst Count
- FCF 7
- TVTX 13
- Target Price
- FCF $19.36
- TVTX $33.17
- AVG Volume (30 Days)
- FCF 581.7K
- TVTX 1.7M
- Earning Date
- FCF 04-22-2025
- TVTX 05-05-2025
- Dividend Yield
- FCF 3.33%
- TVTX N/A
- EPS Growth
- FCF N/A
- TVTX N/A
- EPS
- FCF 1.39
- TVTX N/A
- Revenue
- FCF $448,502,000.00
- TVTX $233,175,000.00
- Revenue This Year
- FCF $11.90
- TVTX $72.95
- Revenue Next Year
- FCF $9.80
- TVTX $53.84
- P/E Ratio
- FCF $11.23
- TVTX N/A
- Revenue Growth
- FCF N/A
- TVTX 60.55
- 52 Week Low
- FCF $12.41
- TVTX $5.12
- 52 Week High
- FCF $19.96
- TVTX $25.29
- Technical
- Relative Strength Index (RSI)
- FCF 34.90
- TVTX 43.78
- Support Level
- FCF $15.23
- TVTX $17.15
- Resistance Level
- FCF $16.58
- TVTX $19.63
- Average True Range (ATR)
- FCF 0.36
- TVTX 1.12
- MACD
- FCF -0.06
- TVTX -0.29
- Stochastic Oscillator
- FCF 17.52
- TVTX 40.33
About FCF First Commonwealth Financial Corporation
First Commonwealth Financial Corp functions in the financial services sector in the United States. Through its subsidiary, it offers a range of consumer and commercial banking services such as personal checking accounts, interest-earning checking accounts, savings accounts, insured money market accounts, investment certificates, fixed & variable rate certificates of deposit, and various kinds of loans. It also provides trust and wealth management services and offers insurance products. The company earns the majority of its revenue through net interest income.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.